Author

S. Healy

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Berhe· 1 shared A. Mottok· 1 shared A. Telenius· 1 shared B. T. Tentokam· 1 shared C. Coelho· 1 shared C. K. Rushton· 1 shared C. Long· 1 shared C. Steidl· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Berhe

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Antibody gene features associated with binding and functional activity in vaccine-derived human mAbs targeting malaria parasites

C. Coelho, S. Marquez, B. T. Tentokam, A. Berhe, k. Miura, C. Long, S. Healy, I. Sagara, S. Kleinstein, P. Duffy

This study identifies antibody gene features linked to binding and functional activity in vaccine-derived human mAbs against malaria parasites, showing adjuvant effects on clonotype diversity.

bioRxiv · Aug 1, 2023 · PreprintImmunology

Non-coding NFKBIZ 3' UTR mutations promote cell growth and resistance to targeted therapies in diffuse large B-cell lymphoma

S. E. Arthur, J. Gao, S. Healy, C. K. Rushton, N. Thomas, L. K. Hilton, K. Dreval, J. Tang, M. Alcaide, R. Cojocaru, A. Mottok, A. Telenius, P. Unrau, W. H. Wilson, L. M. Staudt, , R. D. Morin

This study identifies non-coding NFKBIZ 3' UTR mutations as drivers of DLBCL growth and resistance to NF-κB-targeted therapies, suggesting their potential as biomarkers.

bioRxiv · May 22, 2021 · PreprintCancer Biology